Sandra B. Hake studied biology at RWTH Aachen University and completed her doctorate in molecular immunology at the MPI in Freiburg i.Br. After a PostDoc at the Memorial Sloan-Kettering Cancer Center, she switched to chromatin biology in a second PostDoc, which she carried out in the group of C. David Allis at Rockefeller University, New York, USA.
She continued her work on chromatin as an independent junior research group leader at LMU Munich, where she also habilitated and was awarded the LMU Habilitation Prize. Prof. Hake has been working as a W3 professor at the Institute of Genetics at Justus Liebig University (JLU) Giessen since 2016 and has headed the institute as Managing Director since 2019. Her research group focuses on the regulation of human and murine chromatin structure and gene expression by histone variants and post-translational histone modifications and their dysfunctions in diseases.
